Article information
Full text is only aviable in PDF
REFERENCES
[1]
RC Viney, MJ Boyer, MT King, PM Kenny, CA Pollicino, JM McLean, et al.
Randomized controlled trial of the role of positron emission tomography in the management of stage I and II nonsmall cell lung cancer.
J Clin Oncol., 22 (2004), pp. 2357-2362
[2]
J Mouroux, N Venissac, M Alifano.
Combined video-assisted mediastinoscopy and video-assisted thoracoscopy in the management of lung cancer.
Ann Thorac Surg., 72 (2001), pp. 1698-1703
[3]
J Loscertales, R Jiménez, M Congregado Loscertales, C Arenas, JC Girón, A Arroyo, et al.
Usefulness of videothoracoscopic intrapericardial examination of pulmonary vessels to identify resectable clinical T4 lung cancer.
Ann Thorac Surg., 73 (2002), pp. 563-566
[4]
C Mountain.
Revisions in the International System for staging lung cancer.
Chest, 111 (1997), pp. 1710-1717
[5]
JP Wisnivesky, D Yankelevitz, CI Henschke.
The effect of tumor size on curability of stage I non-small cell lung cancers.
Chest, 126 (2004), pp. 761-765
[6]
J Padilla, JC Peñalver, C Jordá, V Calvo, J Escrivá, J Cerón, et al.
Carcinoma broncogénico no anaplásico de células pequeñas en estadio IA. Cirugía y patrones de mortalidad.
Arch Bronconeumol., 41 (2005), pp. 180-184
[7]
R Giudicelli, P Thomas, T Lonjon, J Ragni, JC Bulgare, R Ottomani, et al.
Major pulmonary resection by video assisted mini-thoracotomy. Initial experience in 35 patients.
Eur J Cardiothorac Surg., 8 (1994), pp. 254-258
[9]
F Gharagozloo, B Tempesta, M Margolis, A Pendleton.
Video-assisted thoracic surgery lobectomy for stage I lung cancer.
Ann Thorac Surg., 76 (2003), pp. 1009-1015
[10]
J Loscertales, R Jiménez, CJ Arenas, JC Girón, M Congregado Loscertales.
Utility of VATS in lung cancer. Valuation of resectability in 296 patients and 72 pulmonary exeresis with radical lymphadenectomy.
Eur J Cardiothorac Surg., 12 (1997), pp. 892-897
[11]
G Roviaro, F Varoli, C Vergani, O Nucca, M Maciocco, F Grignani.
Long-term survival after videothoracoscopic lobectomy for stage I lung cancer.
Chest, 126 (2004), pp. 725-732
[12]
A Iwasaki, T Shirakusa, T Shiraishi, S Yamamoto.
Results of video-assisted thoracic surgery for stage I/II non-small cell lung cancer.
Eur J Cardiothorac Surg., 26 (2004), pp. 158-164
[13]
H Nomori, T Ohtsuda, H Horio, T Naruke, K Suemasu.
Thoracoscopic lobectomy for lung cancer with a largely fused fissure.
Chest, 123 (2003), pp. 619-622
[14]
M Sagawa, M Sato, A Sakurada, Y Matsumura, C Endo, M Handa, et al.
A prospective trial of systematic nodal dissection for lung cancer by video-assisted thoracic surgery: can it be perfect?.
Ann Thorac Surg., 73 (2002), pp. 900-904
[15]
H Nomori, H Horio, T Naruke, K Suemasu.
What is the advantage of a thoracoscopic lobectomy over a limited thoracotomy procedure for lung cancer surgery?.
Ann Thorac Surg., 72 (2001), pp. 879-884
[16]
YC Wu, CF Jeff Lin, WH Hsu, MH Huang, LS Wang.
Long-term results of pathological stage I non-small-cell lung cancer: validation of using the number of totally removed lymph nodes as a staging control.
Eur J Cardiothorac Surg., 24 (2003), pp. 994-1001
[17]
A Gajra, N Newman, GP Gamble, LJ Khoman, SL Graziano.
Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer.
J Clin Oncol., 21 (2003), pp. 1029-1034
[18]
A Campione, T Ligabue, L Luzzi, C Ghiribelli, L Voltolini, P Paladini, et al.
Comparison between segmentectomy and larger resection of non-small cell lung carcinoma.
J Cardiovasc Surg (Torino), 45 (2004), pp. 67-70
[19]
RJ Ginsberg, LV Rubinstein.
Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 N0 nonsmall cell lung cancer.
Ann Thorac Surg., 60 (1995), pp. 615-623
[20]
N Tsubota, K Ayabe, O Doi, T Mori, S Namikawa, T Taki, et al.
Study Group of extended segmentectomy for small lung tumors.
Ann Thorac Surg., 66 (1998), pp. 1787-1790
[21]
H Matsuguma, R Nakahara, M Anraku, T Kondo, Y Tsuura, Y Kamiyama, et al.
Objective definition and measurement method of ground-glass opacity for planning limited resection in patients with clinical stage IA adenocarcinoma of the lung.
Eur J Cardiothorac Surg., 25 (2004), pp. 1102-1106
[22]
R Rosell, J Gómez-Codina, C Camps, J Maestre, J Padilla, A Cantó, et al.
A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer.
N Engl J Med., 330 (1994), pp. 153-158
[23]
SM Keller, MG Vangel, H Wagner, JH Schiller, A Herskovic, et al.
Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.
J Thorac Cardiovasc Surg., 128 (2004), pp. 130-137
[24]
M Inoue, N Sawabata, S Takeda, M Ohta, Y Ohno, H Maeda.
Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumour in the upper lobe.
J Thorac Cardiovasc Surg., 127 (2004), pp. 1100-1106
[25]
F Tanaka, K Yanagihara, Y Otake, Y Kawano, R Miyahara, et al.
Prognostic factors in resected pathologic (p-) stage IIIA-N2, nonsmall-cell lung cancer.
Ann Surg Oncol., 1 1 (2004), pp. 612-618
[26]
S Gabor, H Renner, H Popper, U Anegg, O Sankin, V Matzi, et al.
Invasion of blood vessels as significant prognostic factor in radical resected T1-3N0M0 non-small cell lung cancer.
Eur J Cardiothorac Surg., 25 (2004), pp. 439-442
[27]
A Cyjon, M Nili, G Fink, MR Kramer, E Fenig, J Sandbank, et al.
Advanced non-small cell lung cancer: induction chemotherapy and chemoradiation before operation.
Ann Thorac Surg., 74 (2002), pp. 342-347
[28]
D Galetta, A Cesario, S Margaritora, V Porziella, G Macis, RM D'Angelillo, et al.
Enduring challenge in the treatment of nonsmall cell lung cancer with clinical stage IIIB: results of a trimodality approach.
Ann Thorac Surg., 76 (2003), pp. 1802-1809
Copyright © 2005. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
